greeksoup/ stock research

Nordson Corp.: Q2 FY2026 earnings call

What management said about Q2 FY2026, from the documents filed with the SEC on 20 May 2026: press release. Guidance figures: 2 raised, 2 new. The quarter’s numbers.

Key takeaways

  • Record second-quarter sales, up 8%: Sales reached $741 million, up 8%, with organic growth of 7% and a 3% currency benefit. The divestiture and a small acquisition were a slight offset. Source
  • Adjusted EPS record, up 18%: Adjusted diluted EPS was $2.86, a second-quarter record, compared with $2.42 a year earlier. Source
  • EBITDA record at 32% of sales: EBITDA was $235 million, a second-quarter record, up from $217 million, and held at 32% of sales. Source
  • Backlog up 18% year over year: The company enters the third quarter with backlog up 18% over the prior year, compared with approximately 4% at the start of the second quarter. Source
  • Free cash flow conversion 113%: Year-to-date free cash flow was $293.4 million, with conversion of 113%. Quarter-to-date free cash flow was $170.5 million, with conversion of 119%. Source
  • Pension settlement charge recorded: A one-time, non-cash pension settlement charge of $24.0 million annuitized about 30% of the U.S. pension obligation in the quarter. Source

“Our solid execution of the Ascend Strategy resulted in second quarter records for sales, adjusted earnings and EBITDA.”

Nordson President and Chief Executive Officer Sundaram Nagarajan

Guidance

AreaPeriodFigureAgainst last quarter
Sales SourceThird quarter fiscal 2026$760 to $790 millionNew
Adjusted EPS SourceThird quarter fiscal 2026$2.95 to $3.15 per diluted shareNew
Sales SourceFiscal 2026$2,930 to $3,010 millionRaised from $2,860 to $2,980 million
Adjusted EPS SourceFiscal 2026$11.30 to $11.80 per diluted shareRaised from $11.00 to $11.60 per diluted share

What changed from last quarter

  • Guidance raised: Full year fiscal 2026 sales and adjusted EPS ranges raised, citing end-market momentum, backlog and order entry. Source
  • New guidance: Third quarter fiscal 2026 sales and adjusted EPS ranges given for the first time in this release. Source
  • New: Acquired CapstanAG Systems, a North American precision agriculture company, on March 16, 2026, as a bolt-on to the existing footprint. Source

Results and growth drivers

  • Record second-quarter sales, up 8%: Sales reached $741 million, up 8%, with organic growth of 7% and a 3% currency benefit. The divestiture and a small acquisition were a slight offset. Source
  • Adjusted EPS record, up 18%: Adjusted diluted EPS was $2.86, a second-quarter record, compared with $2.42 a year earlier. Source
  • EBITDA record at 32% of sales: EBITDA was $235 million, a second-quarter record, up from $217 million, and held at 32% of sales. Source
  • Reported EPS up on fewer shares: Reported diluted EPS was $2.09 against $1.97, with diluted shares at 56.1 million versus 57.0 million. Net income was $117 million against $112 million. Source
  • NBS Next framework cited for growth: Management said its NBS Next growth framework, close-to-the-customer model and precision technologies position the company to compound profitable growth. Source

Segments and regions

  • Industrial Precision Solutions record sales: Sales were $350 million, up 10%, with 5% organic growth, 4% from currency and 1% from an acquisition. EBITDA was $124 million, or 35% of sales. Source
  • Medical and Fluid Solutions up 5%: Sales were $213 million, a second-quarter record. Organic growth of 8% was partly offset by 4% from the divested medical contract manufacturing business. EBITDA was $79 million, or 37% of sales. Source
  • Advanced Technology Solutions up 10%: Sales were $178 million, a quarterly record, with 8% organic growth and 2% from currency. EBITDA rose 22% to $48 million, or 27% of sales. Source
  • Europe and Asia Pacific grew fastest: Total sales rose 12.7% in Europe and 9.2% in Asia Pacific, against 5.4% in the Americas, where organic growth was 5.9%. Source

“Our free cash flow conversion also continues to be a strength, enabling a healthy mix of shareholder returns and reinvestment in growth.”

Nordson President and Chief Executive Officer Sundaram Nagarajan

Products, customers and demand

  • Backlog up 18% year over year: The company enters the third quarter with backlog up 18% over the prior year, compared with approximately 4% at the start of the second quarter. Source
  • Order entry broad across segments: Management said order entry momentum was broad-based across all segments in the quarter. Source
  • Electronics dispense drove ATS growth: Advanced Technology Solutions organic growth came from ongoing demand for electronics dispense systems. Source
  • Coating, polymer and agriculture demand: Industrial Precision Solutions organic growth reflected improving coating and polymer processing demand and ongoing precision agriculture growth. Source
  • Engineered fluid and medical lines grew: Medical and Fluid Solutions organic growth came from engineered fluid solutions and medical product lines. Source

Costs, margins and pricing

  • Gross margin slightly lower: Gross margin was 54.5% in the quarter against 54.7% a year earlier, and 54.6% year to date against 54.7%. Source
  • Selling and admin costs rose: Selling and administrative expenses were $206.9 million against $205.2 million. Operating profit rose to $197.2 million from $168.8 million. Source
  • Corporate costs up, interest down: Corporate expenses rose to $15.9 million from $12.4 million. Net interest expense fell to $21.6 million from $26.0 million. Source

“Supported by robust order entry and backlog, we expect this momentum to continue and are increasing our full year sales and earnings guidance.”

Nordson President and Chief Executive Officer Sundaram Nagarajan

Capital, cash and returns to shareholders

  • Free cash flow conversion 113%: Year-to-date free cash flow was $293.4 million, with conversion of 113%. Quarter-to-date free cash flow was $170.5 million, with conversion of 119%. Source
  • Buybacks and dividends continued: Treasury share purchases were $129.3 million year to date, against $146.3 million a year earlier. Dividends paid were $91.6 million, against $88.9 million. Source
  • Long-term debt up, near-term debt down: Long-term debt rose to $1,836 million from $1,681 million at October 31, 2025. Debt due within one year fell to $50 million from $315 million. Source

Non-operating items and adjustments

  • Pension settlement charge recorded: A one-time, non-cash pension settlement charge of $24.0 million annuitized about 30% of the U.S. pension obligation in the quarter. Source
  • Minority investment loss in quarter: A non-cash loss of $9.8 million on minority investments was recorded in the quarter. Year to date, the line shows a $12.4 million gain. Source
  • Adjusted EPS excludes items: Adjusted EPS excluded acquisition amortization of $19.4 million, the pension charge and minority investment items. Year-to-date adjusted EPS was $5.23. Source

Figures management reported

FigureReported
Backlog growth year over year Source18%

Earlier plans management reported on

  • Not stated: Management attributed the second-quarter records to execution of the Ascend Strategy. No status against a stated target was given. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.